IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company
IGC Pharma CEO Ram Mukunda and CFO Claudia Grimaldi purchased an aggregate of 4.27 million shares of common stock at $0.27 per share by cancelling approximately $1.15 million in debt owed to them by the company. The transaction includes over $552,000 in personal cash previously advanced to the company by the executives and eliminates outstanding obligations without any cash payment by IGC.
Key figures
- Offering Price
- 0.27
- Shares Offered
- 4274853
- Total debt cancelled
- 1150000
- Mukunda debt cancelled
- 601148
- Personal cash advanced
- 552362
- Grimaldi debt cancelled
- 553062
- Mukunda shares purchased
- 2226475
- Grimaldi shares purchased
- 2048378
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.